Back to Search
ROBERT GOODRICH, MD CST
MD CST
Obesity Medicine (Family Medicine) Physician
NPI: 1982838264Individual
Specialties, Licenses & Credentials
Obesity Medicine (Family Medicine) PhysicianPrimary
Family Medicine — Obesity Medicine
Code: 207QB0002X
16984(AZ)
Research & Publications (20)
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.
PMID 19682337·Transfusion·2009
8-other
A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.
PMID 19320867·Transfusion·2009
4-observational
Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
PMID 18954398·Transfusion·2009
7-preclinical
Reduction of prion infectivity in packed red blood cells.
PMID 18851948·Biochem Biophys Res Commun·2008
7-preclinical
Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
PMID 18353253·Transfus Med Rev·2008
6-review
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.
PMID 17998874·Transplantation·2007
7-preclinical
Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
PMID 17950672·Transfus Apher Sci·2007
7-preclinical
Success and failure in human spermatogenesis as revealed by teratozoospermic RNAs.
PMID 17327269·Hum Mol Genet·2007
8-other
Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.
PMID 17302769·Transfusion·2007
7-preclinical
Fermi surface changes across the Néel phase boundary of NdB6.
PMID 17155275·Phys Rev Lett·2006
8-other
Use of intraoperative traction sutures in dermatologic surgery as an aid in visualization and stabilization in the operative field.
PMID 17034378·Dermatol Surg·2006
5-case
Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
PMID 16965583·Transfusion·2006
4-observational
The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.
PMID 16935562·Transfus Apher Sci·2006
6-review
Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects.
PMID 16635070·Vox Sang·2006
8-other
Functional inactivation of white blood cells by Mirasol treatment.
PMID 16584442·Transfusion·2006
8-other
Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
PMID 16430665·Vox Sang·2006
7-preclinical
Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.
PMID 16271100·Transfusion·2005
8-other
Recovery of presumptive Alicyclobacillus strains from orange fruit surfacest.
PMID 16245729·J Food Prot·2005
8-other
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
PMID 16078923·Transfusion·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1930 MESQUITE AVE STE 2
LAKE HAVASU CITY, AZ 86403 - Phone
- (928) 854-7962
Quick Facts
- NPI
- 1982838264
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile